Glioblastoma is a particularly aggressive brain tumor that at present is incurable. Cancer doctors can extend patients’ life expectancy through operations, radiation, chemotherapy or surgical interventions. Nevertheless, half of patients die within twelve months of diagnosis.
Takeda wins long-awaited US approval for first oral drug for eosinophilic esophagitis
The FDA on Monday approved Takeda’s Eohilia, the first oral drug for patients with eosinophilic esophagitis (EoE) in the US, which the company briefly abandoned
February 13, 2024